Neuroscience

With our precision neuroscience strategy, we’re transforming care through a targeted and patient-first approach. By leveraging advances in human multi-omics, biologic and digital measures, and therapeutic modalities, we aim to target underlying aspects of disease and predict which patients will benefit most from treatment. We’re building a neuroscience portfolio that meets patients at every step in their journeys, from identification and prevention to treatment and maintenance.

We’re redefining how disease is measured by integrating digital, biological and imaging-based biomarkers, allowing us to track disease progression and therapeutic response in real time. These innovations enable more objective, sensitive and scalable endpoints that better reflect the complexity of brain disorders.

We’re reconceptualizing how we define and measure treatment success by combining clinical data with real-world evidence to prioritize the outcomes that matter most to patients. Our work focuses on capturing meaningful changes in function and ensuring our innovations deliver lasting impact, with the ultimate goal of eliminating some of today’s most prevalent and devastating disorders.